BALVERSA Trademark

Trademark Overview

On Wednesday, March 8, 2017, a trademark application was filed for BALVERSA with the United States Patent and Trademark Office. The USPTO has given the BALVERSA trademark a serial number of 87362785. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2019. This trademark is owned by Johnson & Johnson. The BALVERSA trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceutical preparations for the prevention and treatment of oncologic diseases
balversa

General Information

Serial Number87362785
Word MarkBALVERSA
Filing DateWednesday, March 8, 2017
Status700 - REGISTERED
Status DateTuesday, July 2, 2019
Registration Number5794954
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2017

Trademark Statements

Goods and ServicesHuman pharmaceutical preparations for the prevention and treatment of oncologic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 13, 2017
Primary Code005
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

Trademark Owner History

Party NameJohnson & Johnson
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933
Party NameJohnson & Johnson
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew Brunswick, NJ 08933

Trademark Events

Event DateEvent Description
Tuesday, July 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, March 11, 2017NEW APPLICATION ENTERED
Monday, March 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 1, 2017ASSIGNED TO EXAMINER
Thursday, June 8, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2017PUBLISHED FOR OPPOSITION
Friday, February 15, 2019SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2018SOU TEAS EXTENSION RECEIVED
Thursday, February 22, 2018SOU EXTENSION 1 FILED
Thursday, February 22, 2018SOU EXTENSION 1 GRANTED
Saturday, February 24, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 23, 2018SOU TEAS EXTENSION RECEIVED
Thursday, August 23, 2018SOU EXTENSION 2 FILED
Thursday, August 23, 2018SOU EXTENSION 2 GRANTED
Saturday, August 25, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2019SOU EXTENSION 3 FILED
Friday, February 15, 2019SOU EXTENSION 3 GRANTED
Tuesday, February 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 7, 2019TEAS STATEMENT OF USE RECEIVED
Friday, May 24, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, May 25, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, May 20, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 7, 2019USE AMENDMENT FILED
Monday, May 20, 2019STATEMENT OF USE PROCESSING COMPLETE

Related Keywords

balversa oncologic diseases treatment prevention pharmaceutical preparations human